TSX News -
Bombardier Announces Launch of its New Issuance of Senior Notes due 2032
MONTREAL, May 21, 2024 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) today announced that it has launched an offering of US$500 […]
Blackrock Silver Announces $9 Million Bought Deal Public Offering of Units, Led by Investment from Eric Sprott
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 21, 2024 (GLOBE […]
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
MIAMI, May 21, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), today announced that the U.S. Food […]
Stellantis to Participate in Bernstein 40th Annual Strategic Decisions Conference
Stellantis to Participate inBernstein 40th Annual Strategic Decisions Conference AMSTERDAM, May 21, 2024 – Carlos Tavares, Stellantis Chief Executive Officer, […]
TSX News -
Xtract One Announces Fiscal 2024 Third Quarter Conference Call
TORONTO, May 21, 2024 (GLOBE NEWSWIRE) — Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or […]
BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of Convertible Senior Notes
LOS ANGELES, May 21, 2024 (GLOBE NEWSWIRE) — BlackLine, Inc. (Nasdaq: BL), today announced that it intends to offer, subject […]
KANZHUN LIMITED Announces First Quarter 2024 Financial Results
BEIJING, May 21, 2024 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading […]
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference
Translational data presented during a late-breaker poster session from a head-to-head study of eblasakimab and dupilumab in a human tissue […]
LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results
LAVA-1207 dose escalation progressing in Phase 1/2a trial in prostate cancer, with pembrolizumab combination expected to begin in Q2 2024 […]
Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024
MONTVALE, N.J., May 21, 2024 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and […]
